Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

MabThera/Rituxan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.

MorphoSys eyes 2020 launch for lymphoma CAR-T challenger

MorphoSys eyes 2020 launch for lymphoma CAR-T challenger The data suggests that new antibody could eventually also mount a challenge to Roche’s CD38-targeting Rituxan (rituximab) – also approved as a therapy for DLBCL but facing biosimilar competition – as ... MorphoSys is also carrying out a second

Venclexta plus Gazyva approval adds to non-chemo options in CLL

Venclexta plus Gazyva approval adds to non-chemo options in CLL One example of that is academic research networks who are carrying out their own research of the new agents in combination with Gazyva’s successor treatment, Roche’s off-patent ... Rituxan (rituximab).

Roche and NHS England hail pricing deal on MS drug Ocrevus

Roche and NHS England hail pricing deal on MS drug Ocrevus The approval is good news for Roche, as Ocrevus is one of its most important new products, much needed as its trio of older cancer blockbusters – Avastin, MabThera and Herceptin – go

Hemlibra off to a flyer as Roche raises 2019 forecasts

Hemlibra off to a flyer as Roche raises 2019 forecasts There was some slippage for immunology drug MabThera/Rituxan (rituximab) and Herceptin (trastuzumab) for breast cancer, with the declines seen most starkly in Europe where they fell 38% and 44% respectively.

FDA begins speedy review of Celgene’s Revlimid combo in lymphoma

FDA begins speedy review of Celgene’s Revlimid combo in lymphoma R2 met its primary endpoint of PFS in trials. The FDA has begun a priority review of Celgene’s blood cancer blockbuster Revlimid in combination with Roche’s Rituxan as a ... of non-Hodgkin’s lymphoma), but failed to show any benefit in these

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics